Perspective Therapeutics, Inc. announced a private placement of common shares for the gross proceeds of $20,800,000 on January 18, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.34 USD | -4.42% |
|
+12.59% | +206.97% |
Jul. 01 | Perspective Therapeutics, Inc.(NYSEAM:CATX) added to Russell Small Cap Comp Value Index | CI |
Jul. 01 | Perspective Therapeutics, Inc.(NYSEAM:CATX) added to Russell Small Cap Completeness Index | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+206.97% | 871M | |
+22.15% | 46.55B | |
+45.94% | 41.84B | |
-2.37% | 40.84B | |
+33.84% | 32.95B | |
-6.35% | 28.27B | |
+20.42% | 27.78B | |
+48.83% | 14.26B | |
+45.00% | 13.69B | |
+0.06% | 12.18B |
- Stock Market
- Equities
- CATX Stock
- News Perspective Therapeutics, Inc.
- Perspective Therapeutics, Inc. announced that it expects to receive $20.8 million in funding